Concepedia

D L Behrens

DL

Statistics

Publications

9

Citations

494

H-Index

9

Active since

1988

Affiliations

DuPont (United States)(Current)

Wilmington University

Merck & Co., Inc., Rahway, NJ, USA (United States)

D L Behrens is an author at DuPont (United States) specializing in pharmacology, medicine, and cancer pharmacology.

Publications per year

1988–2005

9

Publications

9

Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity

Charles F. Albright, Nilsa Graciani, Wei Han et al. · Molecular Cancer Therapeutics · 2005 · 104 citations

Medicine, Oncology, Pharmacology +17

Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.

JL Gross, D L Behrens, Deborra Mullins et al. · PubMed · 1988 · 93 citations

Medicine, Biochemistry, Oncology +12

Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium.

Shih-Fong Chen, Frank W. Perrella, D L Behrens et al. · PubMed · 1992 · 84 citations

Life Sciences, Biochemistry, Pharmacology +8

Phospholipase C Inhibitors: A New Class of Agents

Frank W. Perrella, Shih-Fong Chen, D L Behrens et al. · Journal of Medicinal Chemistry · 1994 · 59 citations

Medicine, Medicinal Chemistry, Pharmacology +8

High Throughput Quantitation of cAMP Production Mediated by Activation of Seven Transmembrane Domain Receptors

Ilona Kariv, Michelle E. Stevens, D L Behrens et al. · SLAS DISCOVERY · 1999 · 49 citations

Life Sciences, Biochemistry, Pharmacology +17

1–5 of 9